Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI)

Base Information Edit
  • Chemical Name:5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI)
  • CAS No.:5661-00-7
  • Molecular Formula:C7H8N2
  • Molecular Weight:120.154
  • Hs Code.:
  • Mol file:5661-00-7.mol
5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI)

Synonyms:4,5-Trimethylenepyrimidine;6,7-Dihydro-5H-cyclopenta[d]pyrimidine

Suppliers and Price of 5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI)
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
Total 5 raw suppliers
Chemical Property of 5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI) Edit
Chemical Property:
  • Boiling Point:224℃ 
  • Flash Point:95℃ 
  • PSA:25.78000 
  • Density:1.144 
  • LogP:0.96530 
Purity/Quality:

99% *data from raw suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • General Description 5H-Cyclopentapyrimidine, 6,7-dihydro- (also known as 4,5-trimethylenepyrimidine or 6,7-dihydro-5H-cyclopenta[d]pyrimidine) is a key scaffold in the design of novel vascular endothelial growth factor receptor 2 (VEGFR 2) inhibitors, demonstrating promising anti-cancer potential. Derivatives of this scaffold, such as compounds 6c and 6b, exhibit significant VEGFR 2 inhibition, with 97% and 87% enzyme inhibition at 10 μM, respectively. By targeting VEGFR 2, these compounds disrupt angiogenesis, thereby suppressing tumor growth and metastasis, highlighting their therapeutic relevance in cancer treatment.
Technology Process of 5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI)

There total 13 articles about 5H-Cyclopentapyrimidine, 6,7-dihydro- (6CI,7CI,8CI,9CI) which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With ammonium acetate; In methanol; at 65 ℃; for 48h;
Guidance literature:
With triethylamine; pyrrolidine-2-carboxylic acid amide; In dimethyl sulfoxide; at 90 ℃; for 24h; regioselective reaction;
DOI:10.1039/c5ra16995j
Guidance literature:
In 1,4-dioxane; at 90 ℃; for 5h;
DOI:10.1021/jo00134a034
Refernces Edit

3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation

10.1016/j.bioorg.2019.102988

The study focuses on the design, synthesis, and biological evaluation of a novel chemical scaffold, 6,7-dihydro-5H-cyclopenta[d]pyrimidine derivatives, as inhibitors of vascular endothelial growth factor receptor 2 (VEGFR 2). The research involved molecular modeling protocols, including 3D-QSAR pharmacophore modeling, virtual screening, and docking studies, to identify and design potential VEGFR 2 inhibitors. The chemicals used in the study include a series of synthesized 6,7-dihydro-5H-cyclopenta[d]pyrimidine derivatives, with compounds 6c and 6b showing significant enzyme inhibition of 97% and 87% at 10 μM, respectively. These compounds were designed to target the VEGFR 2 receptor, which plays a crucial role in angiogenesis and is a key therapeutic target for inhibiting tumor growth and metastasis. The purpose of these chemicals was to serve as potential anti-cancer agents by inhibiting the VEGFR 2 signaling pathway, thereby affecting the blood supply to tumor cells and inhibiting their growth and spread.

Post RFQ for Price